Introduction
Photon counting CT uses energy resolving detectors to provide spectral information and improved spatial resolution compared with conventional CT. Spectral imaging enables material decomposition virtual non contrast images and improved contrast to noise ratio. Clinical applications include vascular imaging oncology and musculoskeletal assessment.
Technical Advantages
Photon counting detectors reduce electronic noise and allow smaller detector elements for higher spatial resolution. Spectral data supports material separation such as iodine calcium and uric acid and improves lesion conspicuity. Dose efficiency and artifact reduction are potential benefits in many protocols.
Clinical Use Cases
Spectral CT aids in characterizing renal and adrenal lesions vascular plaque composition and enhancing tumor detection and characterization. It supports virtual monoenergetic reconstructions that improve contrast in low dose studies. Adoption requires protocol development and radiologist training to interpret spectral outputs.
Implementation Challenges
New detector technology requires vendor specific reconstruction and postprocessing tools and validation across clinical indications. Cost and integration with existing workflows influence adoption timelines. Multicenter studies and consensus guidelines will guide standardized clinical use.